Metraipolis › archive › dc_f096fa697d9c
Targeting BCL11B-mediated JAK2/STAT3 activation: A novel therapeutic strategy for Parkinson's disease — Europe PMC PMID:42898226
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42898226
- DOI
- 10.1016/j.isci.2026.117833
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T04:42:03.260Z
- SHA-256 of the archived text
4080260ac4df4f43f08fec554e334526500d3331311ea7200a1f3c2d9dd44175- Stable URL of this page
https://metraipolis.com/documento/dc_f096fa697d9c
How to cite
Targeting BCL11B-mediated JAK2/STAT3 activation: A novel therapeutic strategy for Parkinson's disease — Europe PMC PMID:42898226 — Europe PMC (en), https://europepmc.org/article/MED/42898226 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f096fa697d9c (Metraipolis archive dc_f096fa697d9c, sha256 4080260ac4df4f43f08fec554e334526500d3331311ea7200a1f3c2d9dd44175)
BibTeX
@misc{dcf096fa697d9c,
title = {Targeting BCL11B-mediated JAK2/STAT3 activation: A novel therapeutic strategy for Parkinson's disease — Europe PMC PMID:42898226},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42898226},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f096fa697d9c; sha256 4080260ac4df4f43f08fec554e334526500d3331311ea7200a1f3c2d9dd44175},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42898226. Agents can read the archived copy with the MCP tool read_document.